www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

ALK — Financial calendar for the 2012 financial year

December 09, 2011

PDF Version

Supporting Materials:
FM_25_11UK_09122011.pdf

 

Copenhagen, 2011-12-09 11:11 CET (GLOBE NEWSWIRE) --  

Annual report 2011                                                     22 February 2012

Annual General Meeting to be held                                  27 March 2012
at ALK                                                                                  4.00 p.m.
Bøge Allé 1
2970 Hørsholm, Denmark

Written requests to have specific business
transacted at the AGM will be included in the agenda
if received by the company on 13 February 2012 at the latest
(may be e-mailed to investor@alk-abello.com)

 

Three-month interim report (Q1) 2012                                  10 May 2012

Six-month interim report (Q2) 2012                                 16 August 2012

Nine-month interim report (Q3) 2012                           12 November 2012

 

ALK-Abelló A/S
 

Jens Bager
President and CEO

 

For further information please contact:
Per Plotnikof, Investor Relations Director, tel. +45 4574 7527

 

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved